Predictive factors for secondary postpartum hemorrhage: a case-control study in Japan

Shinohara, Satoshi; Okuda, Yasuhiko; Hirata, Shuji; Suzuki, Kohta

doi:10.1080/14767058.2020.1844654

Cited by 2 publications

(4 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Week of birth was selected to adjust for any management changes evoked by COVID‐19, weather, or unit activity at a particular time. Parity was matched as an accepted risk factor for PPH, and may influence postnatal costs that are lower in parity than nulliparous women 3 . Maternal age was selected due to established data that younger and older mothers experience higher rates of complications that may impact cost 16 …”

Section: Methodsmentioning

confidence: 99%

“…Parity was matched as an accepted risk factor for PPH, and may influence postnatal costs that are lower in parity than nulliparous women. 3 Maternal age was selected due to established data that younger and older mothers experience higher rates of complications that may impact cost. 16 Within the study group, episodes of care relating to the management of secondary PPH occurred up to 14 weeks postpartum.…”

Section: Methodsmentioning

confidence: 99%

“…Secondary postpartum haemorrhage (PPH) is defined as abnormal or excessive vaginal bleeding which occurs more than 24 h after delivery and up to 12 weeks postpartum 1,2 . The incidence of secondary PPH varies from 0.2–3.0% of women, and typically postnatally presents between 1–2 weeks 3–5 . The most common causes are endometritis and retained products of conception (RPOC); thus management of patients presenting with secondary PPH focuses on diagnosing and treating these conditions 6,7 .…”

Section: Introductionmentioning

confidence: 99%

“…

PPH varies from 0.2-3.0% of women, and typically postnatally presents between 1-2 weeks. [3][4][5] The most common causes are endometritis and retained products of conception (RPOC); thus management of patients presenting with secondary PPH focuses on diagnosing and treating these conditions. 6,7 Despite its impact on morbidity, there is a lack of evidence to guide clinicians managing this condition and in understanding the cost burden of disease, compared to primary PPH.

…”

mentioning

confidence: 99%

See 3 more Smart Citations

Economic cost of secondary postpartum haemorrhage: A case–control study at a tertiary hospital in Australia

Young

Quinlivan

Fox

et al. 2023

Aust NZ J Obst Gynaeco

View full text Add to dashboard Cite

Background Secondary postpartum haemorrhage (PPH) is a condition which affects 0.2–3.0% of women. Despite its impact on maternal morbidity, there is a lack of understanding of the cost burden of disease. Aims To determine the economic cost of secondary PPH in the postpartum period, compared to the costs for women without this diagnosis. Materials and methods Data were prospectively collected on a cohort of 97 women who presented with secondary PPH to the emergency department (ED) between July 2020 and February 2021. A case–control design was then used to compare postpartum cost data from these patients to a group of 97 controls who were matched to maternal demographics, and who did not present with secondary PPH. Results For women with secondary PPH, there were significantly more hospital attendances, and postpartum costs were higher for all cost subcategories across ED, admissions, and outpatient attendances (P < 0.0001), compared to controls. The total cost of postpartum care for 97 patients with secondary PPH was $254 377.62 with an average cost per patient of $2622.45, compared to $26 670.46 for 97 controls with an average cost of $274.95 per patient (P < 0.0001). This demonstrates a 9.5‐fold increase in postpartum costs per woman with secondary PPH. Conclusions Secondary PPH is an under‐researched condition which presents a significant cost burden for the health system. Evidence‐based guidelines addressing the prevention and management of secondary PPH may assist in minimising this cost burden for both the health service and the patient.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%